tiprankstipranks
Verve Therapeutics (VERV)
NASDAQ:VERV
US Market
Holding VERV?
Track your performance easily

Verve Therapeutics (VERV) Technical Analysis

562 Followers

Technical Sentiment

Overall Consensus
Strong Buy
15Bullish
5Neutral
2Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
11Bullish
0Neutral
1Bearish
Verve Therapeutics’s (VERV) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Verve Therapeutics is a Buy.
Verve Therapeutics’s (VERV) 20-Day exponential moving average is 5.86, while Verve Therapeutics’s (VERV) share price is $6.14, making it a Buy.
Verve Therapeutics’s (VERV) 50-Day exponential moving average is 5.82, while Verve Therapeutics’s (VERV) share price is $6.14, making it a Buy.

Verve Therapeutics (VERV) Pivot Points

Jan 20, 2025, 10:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.74
5.03
5.56
5.85
6.38
6.67
7.20
Fibonacci
5.03
5.34
5.54
5.85
6.16
6.36
6.67
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verve Therapeutics (VERV) Moving Averages

Jan 20, 2025, 10:24 PM
Period
Simple
Exponential
MA5
5.70Buy
5.88Buy
MA10
5.91Buy
5.85Buy
MA20
5.81Buy
5.86Buy
MA50
5.85Buy
5.82Buy
MA100
5.63Buy
5.95Buy
MA200
5.86Buy
6.97Sell
Verve Therapeutics’s (VERV) 10-Day exponential moving average is 5.85, while Verve Therapeutics’s (VERV) share price is $6.14, making it a Buy.
Verve Therapeutics’s (VERV) 100-Day exponential moving average is 5.95, while Verve Therapeutics’s (VERV) share price is $6.14, making it a Buy.
Verve Therapeutics’s (VERV) stock price is $6.14 and Verve Therapeutics’s (VERV) 50-day simple moving average is 5.85, creating a Buy signal.
Verve Therapeutics’s (VERV) stock price is $6.14 and Verve Therapeutics’s (VERV) 100-day simple moving average is 5.63, creating a Buy signal.
Verve Therapeutics’s (VERV) stock price is $6.14 and Verve Therapeutics’s (VERV) 200-day simple moving average is 5.86, creating a Buy signal.

Verve Therapeutics (VERV) Technical Indicators

Jan 20, 2025, 10:24 PM
Name
Value
Implied Action
RSI (14)
53.75
Neutral
STOCH (9,6)
43.02
Neutral
STOCHRSI (14)
43.02
Neutral
MACD (12,26)
>-0.01
Buy
ADX (14)
14.00
Buy
Williams %R
-43.26
Buy
CCI (14)
88.80
Neutral
ATR (14)
0.55
-
Ultimate Oscillator
41.20
Neutral
ROC
-2.54
Sell
Verve Therapeutics’s (VERV) Relative Strength Index (RSI) is 53.75, creating a Neutral signal.
Verve Therapeutics’s (VERV) Trend Strength Indicator (ADX) is 14.00, creating a Buy signal.
Verve Therapeutics’s (VERV) Commodity Channel Index (CCI) is 88.80, creating a Neutral signal.
Verve Therapeutics’s (VERV) Price Rate of Change (ROC) is -2.54, creating a Sell signal.

FAQ

Is VERV a Buy, Hold, or Sell?
Based on VERV’s technical indicators, VERV is a Strong Buy.
    What is VERV’s RSI (14)?
    VERV’s RSI (14) is 53.75, which suggests VERV is a Neutral.
      What is VERV’s MACD?
      VERV’s MACD is >-0.01, which suggests VERV is a Buy.
        What is VERV’s 5-day moving average?
        VERV’s 5-day moving average is 5.70, which suggests VERV is a Buy.
          What is VERV’s 20-day moving average?
          VERV 20-day moving average is 5.81, which suggests VERV is a Buy.
            What is VERV’s 50-day moving average?
            VERV’s 50-day moving average is 5.85, which suggests VERV is a Buy.
              What is VERV’s 200-day moving average?
              VERV’s 200-day moving average is 5.86, which suggests VERV is a Buy.
                What is VERV’s Williams % R (14)?
                VERV’s Williams % R (14) is -43.26, which suggests VERV is a Buy.
                  What is VERV’s CCI (14)?
                  VERV’s CCI (14) is 88.80, which suggests VERV is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis